Cancer Research

AI and Registry Data Identify High-Risk Melanoma Patients
Tech & Innovation AI and Registry Data Identify High-Risk Melanoma Patients

The silent progression of melanoma often remains undetected until it reaches a critical stage, yet the digital fingerprints of this disease may already exist within the vast archives of national healthcare databases. A transformative study led by researchers at the University of Gothenburg and

Mitochondrial Hub Controls Dendritic Cell Immune Readiness
Research & Development Mitochondrial Hub Controls Dendritic Cell Immune Readiness

Within the microscopic theater of the human body, a relentless surveillance network operates with such precision that most pathogens are neutralized long before symptoms ever appear. At the heart of this defensive perimeter are dendritic cells, the primary "sentinels" that bridge the gap between

OHSU Leads $9.2 Million Effort for Next-Gen Cancer Models
Research & Development OHSU Leads $9.2 Million Effort for Next-Gen Cancer Models

The traditional landscape of oncological drug development is currently undergoing a massive transformation as Oregon Health & Science University launches an ambitious $9.2 million initiative to redefine the accuracy of preclinical testing. By establishing the Knight Cancer Precision Biofabrication

Can Oricell’s $110M Round Unlock CAR-T for Solid Tumors?
Research & Development Can Oricell’s $110M Round Unlock CAR-T for Solid Tumors?

While chimeric antigen receptor T-cell therapy has already revolutionized the treatment of hematologic malignancies, the biological fortress surrounding solid tumors continues to pose a formidable challenge for researchers and clinicians alike. Unlike the relatively accessible nature of blood

Can Daraxonrasib Transform Pancreatic Cancer Treatment?
Research & Development Can Daraxonrasib Transform Pancreatic Cancer Treatment?

The pursuit of a reliable therapeutic strategy for metastatic pancreatic ductal adenocarcinoma has remained one of the most frustrating and stagnant chapters in modern oncology for decades. This specific malignancy is notorious for its silent progression, aggressive biological behavior, and a

Can DHODH Inhibition Overcome Lung Cancer Radiation Resistance?
Research & Development Can DHODH Inhibition Overcome Lung Cancer Radiation Resistance?

The persistent struggle against lung cancer has long relied on radiation therapy to dismantle the genetic integrity of malignant cells, yet many aggressive tumors possess an uncanny ability to withstand these high-energy assaults. Recent breakthroughs from The University of Texas MD Anderson Cancer

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later